Nome del prodotto: Dehydronandrolone Acetate
Sinonimi: Dehydronandrolone Acetate;Dehydronandrolone-6 Acetate
CAS: 2590-41-2
MF: C20H26O3
MW: 314.42
deputato: 95-98°C
Temp. di conservazione: Controlled Substance, -20°C Freezer
Aspetto: polvere bianca
Dehydronandrolone acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate(CAS: 2590-41-2) is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate is an effective compound that produces quality, long-lasting muscle gains,with the biggest side effect being water retention.
| Elementi di analisi |
Specifica |
Risultati |
| Descrizione |
White to light yellow crystalline powder |
Polvere cristallina bianca |
| Punto di fusione |
≥100℃ |
107℃ |
| Rotazione ottica specifica |
-20°～-26° |
-22.5° |
| Perdita all'essiccazione |
≤0,5% |
0.15% |
| Identificazione |
Test preparation has maximum
absorption at 282±2nm by
ultraviolet – visible spectrophotometry. |
Qualificato |
| Maximum single impurity |
≤1,0% |
0.3% |
| Impurità totali |
≤5,0% |
0.8% |
| Analisi |
≥95,0% |
99.45% |
| Conclusione |
Qualificato |
